Publication:
The role of claudin-6 in chromophobe renal cell carcinoma

Thumbnail Image
Files
Erlmeier-38-403-407-2023.pdf(1.39 MB)
Date
2023
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Erlmeier, Franziska ; Zschäbitz, Stefanie ; Mikuteit, Marie ; Autenrieth, Michael ; Weichert, Wilko ; Hartmann, Arndt ; Steffens, Sandra
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de Biología Celular e Histología
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-520
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. The prognostic value of Claudin-6 (CLDN6) in non clear cell renal cell carcinoma (RCC) is still unclear. Aim. To evaluate the prognostic impact of CLDN6 expression in a large cohort of chromophobe RCC (chRCC). Material and Methods. Patients who underwent renal surgery due to chRCC were recruited. Clinical data were retrospectively evaluated. Tumor specimens were analyzed for CLDN6 expression by immunohistochemistry. Results. 81 chRCC patients were eligible for analysis, thereof 10 (12.3%) patients were positive for CLDN6. No significant associations were found for CLDN6 expression and clinical attributes in patients with chRCC. Kaplan-Meier analysis revealed no differences in overall survival (OS) for patients with CLDN6- compared to CLDN6+ tumors (87.0% versus 62.5%; p=0.174). Conclusion. In chRCC CLDN6 expression is not associated with parameters of aggressiveness or survival. Due to the rare incidence of chRCC further studies with larger cohorts are warranted.
publication.page.subject
Renal Cell Carcinoma , Claudin-6 , Chromophobe histology , Survival
Citation
Histology and Histopathology, Vol.38, nº4, (2023)
URI
http://hdl.handle.net/10201/129708
item.page.embargo
Collections
Histology and histopathology Vol.38, nº4 (2023)
Ir a Estadísticas